1 / 6

Rallis India Limited (RALLIS) - Financial and Strategic SWOT

April 17th, 2015 – Navi Mumbai, India: Market Reports on India presents the report on "Rallis India Limited (RALLIS) - Financial and Strategic SWOT Analysis Review" The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

SophiaJones
Download Presentation

Rallis India Limited (RALLIS) - Financial and Strategic SWOT

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Parenteral Drug India Ltd. (PDPL) - Financial and Strategic SWOT Analysis Review Market Reports On India www.marketreportsonindia.com

  2. Summary Parenteral Drugs (India) Limited (Parenteral Drugs) is a pharmaceutical company. The company discovers, researches, develops and manufactures pharmaceutical products. Its products include solid and liquid orals, IV fluids, oncology products and critical care products. Parenteral Drugs also provides I.V. Paracetamol, propofol and other anesthesia products. The company offers products in dosage forms of intravenous infusion, tablets, capsules, liquids syrups and injections. It has manufacturing units in Madhya Pradesh, Himachal Pradesh, Punjab and Goa. The company’s international manufacturing units are located in Mauritius, Nairobi and Kazakhstan. It exports its products to African, Russian, Middle Eastern, Asian and CIS countries. Parenteral Drugs is headquartered in Mumbai, Maharashtra, India. Parenteral Drug India Ltd. Key Recent Developments May 30, 2013: Parenteral Drug Reports Revenue Of INR1.9 Billion In Fiscal 2013 Jan 30, 2013: Parenteral Drug Reports Revenue Of INR390.1m In Q3 Fiscal 2013 Contact No: +91.22.27810772, 27810773 Email Id : info@marketreportsonindia.com

  3. This comprehensive SWOT profile of Parenteral Drug India Ltd. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. The profile contains critical company information including, - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – Analyst’s summarization of the company’s business strategy. - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. Contact No: +91.22.27810772, 27810773 Email Id : info@marketreportsonindia.com

  4. Key employees – A list of the key executives of the company.  • - Executive biographies – A brief summary of the executives’ employment history.  • - Key operational heads – A list of personnel heading key departments/functions.  • - Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.  • - Key manufacturing facilities – A list of key manufacturing facilities of the company.  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history. •  - Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history. Contact No: +91.22.27810772, 27810773 Email Id : info@marketreportsonindia.com

  5. Table of Contents Section 1 - About the Company Parenteral Drug India Ltd. - Key Information Parenteral Drug India Ltd. - Overview Section 2 - Company Analysis Parenteral Drug India Ltd. - Business Description Parenteral Drug India Ltd. - Corporate Strategy Section 3 - Company Financial Performance Charts Parenteral Drug India Ltd. - Financial Ratios Financial Ratios - Capital Market Ratios Section 4 - Appendix Appendix Methodology Contact No: +91.22.27810772, 27810773 Email Id : info@marketreportsonindia.com

  6. To know more : Parenteral Drug India Ltd. (PDPL) - Financial and Strategic SWOT Analysis Review Contact Us : Ph : India : +91.22.27810772, 27810773Email : info@marketreportsonindia.comWeb : http://www.marketreportsonindia.com/

More Related